Haroon A Mann: Focusing on Inequities in Haemophilia Care in Low-Resource Settings at WHC 2026
Haroon A Mann, Consultant Trauma and Orthopaedic Surgeon at Royal Free Hospital London NHS Foundation Trust, shared on LinkedIn:
”Attending the World Haemophilia Congress in Kuala Lumpur this week has reinforced something I’ve seen throughout 20 years in medicine, orthopaedics and trauma surgery.
In well-resourced systems, haemophilia is a manageable condition – safe surgery, reliable factor access, predictable outcomes.
Data and outcomes from my institution in The Royal Free London NHS dates back over 60 years, undertaking safe and effective orthopaedic surgery in haemophilic patients.
In many lower-resource settings, lack of access to basic clotting factor still turns routine surgery into high-risk or impossible care.
In developed healthcare systems, we are fortunate and able to undertake complex orthopaedic procedures with confidence, supported by amazing experts with reliable and timely access to clotting factors.
In contrast, in many developing settings, even basic surgical interventions may be deferred or avoided entirely due to life threatening bleeding risk and lack of resources.
Patients with haemophilia who sustain trauma – whether from road traffic accidents or due to lack of infrastructure , may have limited or no access to clotting factor at all, with catastrophic and often fatal bleeding risk.
The result is not a lack of medical knowledge – but a lack of system capacity.
This too remains an under-recognised dimension of conflict medicine and health security.
The science exists. The inequality is systemic.”
Stay updated with Hemostasis Today.
-
May 19, 2026, 11:15Sarah-Anne Nicholas: Excited to Share My First-Author Publication from My PhD Research
-
May 19, 2026, 10:45Jonathan Douxfils: Why Measuring NETosis Remains a Major Challenge in Translational Research
-
May 19, 2026, 10:39Maria Berghs: Rising Demand for Blood Donations in Sickle Cell Care
-
May 19, 2026, 10:27Amer Zeidan: Looking Forward to Sharing New AML Data at ESH 2026
-
May 19, 2026, 09:38Heghine Khachatryan: Why DVT in Elderly Patients Requires Special Attention?
-
May 19, 2026, 08:52Konstantin Stark: Announcing the Launch of Collaborative Research Center 1784 to Advance Thromboinflammation Research
-
May 19, 2026, 08:35Gokhan Ozdemir: Managing Acute Flow Diverter Stent Thrombosis in a Critical Vertebrobasilar Circulation
-
May 19, 2026, 08:28Rashad Falah: Evaluating Long Term Outcomes and Transfusion Risks in Obscure Gastrointestinal Bleeding
-
May 18, 2026, 16:35Abdurrahmaan Ali Suei Elbuzidi: What is the Optimal Anticoagulation Monitoring Target in ECMO?